Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation

C Schiliro, BL Firestein - Cells, 2021 - mdpi.com
Cancer cells alter metabolic processes to sustain their characteristic uncontrolled growth
and proliferation. These metabolic alterations include (1) a shift from oxidative …

Lipid composition of the cancer cell membrane

W Szlasa, I Zendran, A Zalesińska, M Tarek… - Journal of bioenergetics …, 2020 - Springer
Cancer cell possesses numerous adaptations to resist the immune system response and
chemotherapy. One of the most significant properties of the neoplastic cells is the altered …

Estrogen receptor signaling in the immune system

B Chakraborty, J Byemerwa, T Krebs, F Lim… - Endocrine …, 2023 - academic.oup.com
The immune system functions in a sexually dimorphic manner, with females exhibiting more
robust immune responses than males. However, how female sex hormones affect immune …

Insights into new mechanisms and models of cancer stem cell multidrug resistance

Y Garcia-Mayea, C Mir, F Masson, R Paciucci… - Seminars in cancer …, 2020 - Elsevier
The acquisition of genetic alterations, clonal evolution, and the tumor microenvironment
promote cancer progression, metastasis and therapy resistance. These events correspond …

Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action

KM Yap, M Sekar, LJ Seow, SH Gan… - … Cancer: Targets and …, 2021 - Taylor & Francis
Globally, breast cancer is the most common cancer type and is one of the most significant
causes of deaths in women. To date, multiple clinical interventions have been applied …

Beyond lipid-lowering: effects of statins on cardiovascular and cerebrovascular diseases and cancer

Y Morofuji, S Nakagawa, K Ujifuku, T Fujimoto… - Pharmaceuticals, 2022 - mdpi.com
The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, also known
as statins, are administered as first-line therapy for hypercholesterolemia, both as primary …

[HTML][HTML] Drug uptake-based chemoresistance in breast cancer treatment

H Muley, R Fado, R Rodriguez-Rodriguez… - Biochemical …, 2020 - Elsevier
Breast cancer is the most prevalent type of tumor and the second leading cause of death
due to cancer among women. Although screening methods, diagnosis and therapeutic …

Updating the role of obesity and cholesterol in breast cancer

L Garcia-Estevez, G Moreno-Bueno - Breast Cancer Research, 2019 - Springer
Background Breast cancer is the second most common cause of cancer-related death
among women. Advances in our understanding of the disease have translated into better …

Antibody conjugation of nanoparticles as therapeutics for breast cancer treatment

A Juan, FJ Cimas, I Bravo, A Pandiella… - International journal of …, 2020 - mdpi.com
Breast cancer is the most common invasive tumor in women and the second leading cause
of cancer-related death. Nanomedicine raises high expectations for millions of patients as it …

[HTML][HTML] Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms

AF Hassanabad - Translational Lung Cancer Research, 2019 - ncbi.nlm.nih.gov
Statins have been shown to inhibit cell proliferation in vitro and tumor growth in animal
models. Various studies have also shown a decreased cancer-specific mortality rate in …